Antipyretic TRIZ Cases

Specific nucleic acid aptamers neutralize c-Met signaling pathways, resolving the lack of effective binding substances for cancer diagnosis and treatment.

Fully human monoclonal antibodies against OX40 reduce immunogenicity while enhancing T cell proliferation and cytokine production.

Combining methotrexate with simvastatin reduces severe neurotoxicity and myelosuppression while maintaining therapeutic efficacy in osteosarcoma treatment.

Using cell lines expressing functional large T antigen without small T antigen enables scalable production of safe, non-replicating viral vectors.

Optimized monoclonal antibodies bind CTLA-4 with superior affinity, resolving insufficient blocking activity in existing therapies.

A pharmaceutical composition containing pinitol or D-chiro-inositol alleviates premenstrual syndrome symptoms.

A polymer matrix device combines methyl salicylate with essential oils to accelerate transdermal transport of the active agent.

A biotinylation protocol isolates the Plg-RKT membrane protein using affinity chromatography and MudPIT analysis.

Humanized CD3 antibodies form multispecific complexes that activate T cells to recognize and kill cancer cells.

Guava leaf extract elevates blood adiponectin levels, addressing the lack of safe long-term therapeutic substances.

Composite polymer matrices stabilize high-concentration bio-fermented sodium hyaluronate, resolving viscosity and degradation bottlenecks.

Targeted inhibitors reduce toxicity while eliminating tumorigenic potential in aggressive basal-like cancers.

Amino acid substitutions in the antibody Fc region enhance FcRn receptor binding affinity.

A cannabis and avocado soybean unsaponifiables composition reduces inflammatory responses through synergistic modulation of cytokine production.

Molten NSAID mixes with paracetamol into solidified melt granules, resolving slow disintegration and complex excipient requirements.

Propionibacterium freudenreichii UF1 postbiotics reduce body fat and prevent obesity while improving insulin sensitivity and lowering inflammation.

A polyspecific monoclonal antibody binds multiple CCR3-binding chemokines to inhibit cell migration.

Administered osteoblasts mediate immune modulation and tissue repair to address underlying pathology and bone lesions.

Monoclonal antibodies target IL-6 pathways to reduce proteinuria while avoiding broad immunosuppression side effects.

Secondary carbamate linkers enable predictable drug release by avoiding isocyanate formation and uncontrolled burst effects.

Selective antibodies inhibit the alternative complement pathway to reduce arthritis inflammation while preserving classical pathway host defense mechanisms.

Co-crystallization of meloxicam with acids improves bioavailability by resolving the contradiction between chemical stability and prolonged absorption rates.

Micronized placental particles combined with bone grafts improve fusion rates while reducing post-surgical inflammation.

Thiophosphate compounds protect fluoroolefins from high-temperature oxidation in refrigeration systems.

Antibodies bind CSF1R to block ligand interaction, reducing cytokine levels in inflammatory disease.

Combining laquinimod with methotrexate treats rheumatoid arthritis through synergistic anti-inflammatory action.

A probiotic formulation containing Bifidobacterium bifidum MIMBb75 strengthens the intestinal barrier to treat gastrointestinal diseases.

Hydrolyzable prodrug linkages enable controlled resiniferatoxin release, reducing opioid addiction risks while maintaining TRPV1 agonism.

Antibodies 9-10.2 and 8-4.1 recognize the caspase-cleaved neoepitope of IL-18, enabling accurate measurement without cross-reactivity to pro-IL-18.

A thermosensitive chitin hydrogel forms a gel at body temperature to release local anesthetic drugs.

Phospholipid-curcumin complexes resolve low bioavailability and NSAID side effects by stabilizing curcumin at physiological pH.

Resins and polysaccharides in the formulation boost tannin binding to mucous membranes, reducing systemic toxicity while maintaining therapeutic efficacy.

A cyclosporin formulation uses a hydrogel polymer matrix and specific surfactants to maintain the drug in a solubilized state within an emulsion.

Silica adsorbent selectively recovers hydrophobic peptides from plant oils.

Anti-CD20 antibodies deplete CD20+ B-cells to reduce pulmonary inflammation and improve lung function despite smoking cessation.

A composite phyto-extract mixture leverages isoegomaketone and atlactylenolide for therapeutic action.

Low-temperature citric acid reaction and ultrafiltration isolate active fractions without high energy costs.

Humanized monoclonal antibodies bind properdin to block the alternative complement pathway.

A cell-free fat extract rich in growth factors treats arthritis by inhibiting fibrosis and improving chondrocyte health.

A supersaturated acetaminophen solution provides prolonged spinal analgesia through controlled phase transitions.

Supercritical carbon dioxide selectively extracts galangin from Alpiniae Officinarum Rhizome superfine powder, reducing acrid taste and solvent use.

Evans blue targets dorsal root ganglia to suppress neuronal hyperexcitation.

PLA2 inhibitors stabilize sepsis patients before diagnosis, preserving antibiotic effectiveness.

A swallowable capsule advances anti-interleukin antibody preparations directly into the intestinal wall using a tissue-penetrating mechanism.

Engineered Fc regions eliminate antibody-dependent enhancement risk while extending serum half-life for effective prophylactic treatment.

Segmented polymer platforms use intermediary linkers to simplify synthesis while maintaining selective delivery.

Honey fortified with methylglyoxal and mineral salts reduces wound protease activities and suppresses infections without synthetic pharmaceutical side effects.

Weight-based ravulizumab dosing regimens inhibit terminal complement C5 to reduce muscle weakness and cutaneous symptoms in dermatomyositis patients.

Selective anti-CCL17 antibodies neutralize pathological Th2 responses while preserving beneficial innate immune functions mediated by CCL22.